These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1269288)

  • 1. Comparative studies of the activity of ciclacillin and dicloxacillin.
    Mückter H; Sous H; Poszich G; Arend P
    Chemotherapy; 1976; 22(3-4):183-9. PubMed ID: 1269288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microbiological properties of a dicloxacillin-hetacillin combination.
    Renzini G; Ravagnan G; Oliva B
    Chemotherapy; 1973; 19(6):367-78. PubMed ID: 4603149
    [No Abstract]   [Full Text] [Related]  

  • 3. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin.
    Sutherland R; Croydon EA; Rolinson GN
    Br Med J; 1970 Nov; 4(5733):455-60. PubMed ID: 5481218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of thioridazine and dicloxacillin as a possible treatment strategy of staphylococci.
    Rasmussen KS; Poulsen MØ; Jacobsen K; Skov MN; Kolmos HJ; Kallipolitis BH; Klitgaard JK
    New Microbiol; 2017 Apr; 40(2):146-147. PubMed ID: 28255602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of the resistance behavior of staphylococci to isoxazolyl penicillins (oxa-, cloxa-, and dicloxacillin)].
    Matz K; Schassan HH; Faerber CH; Kornmüller KJ
    Zentralbl Bakteriol Orig A; 1974; 228(1):270-2. PubMed ID: 4154678
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of minimum inhibitory concentrations of group M penicillins against Staphylococcus aureus. Practical impact on diagnosis and treatment].
    de Rautlin de la Roy Y; Grignon B; Castel O
    Pathol Biol (Paris); 1987 Sep; 35(7):1057-61. PubMed ID: 3313213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro and in vivo activity of a new semisynthetic penicillin: flucloxacillin].
    Renzini G; Bevilacqua R; Oliva B; Ravagnan G
    Farmaco Sci; 1973 Sep; 28(9):733-40. PubMed ID: 4749859
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of dicloxacillin and fusidic acid on the extracellular and intracellular killing of Staphylococcus aureus.
    Nielsen SL; Black FT
    J Antimicrob Chemother; 1998 Aug; 42(2):221-6. PubMed ID: 9738840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of parenteral dicloxacillin.
    Deresinski SC; Stevens DA
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):151-62. PubMed ID: 809231
    [No Abstract]   [Full Text] [Related]  

  • 10. Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro.
    Sandberg A; Jensen KS; Baudoux P; Van Bambeke F; Tulkens PM; Frimodt-Møller N
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2391-400. PubMed ID: 20308386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro examination on antibacterial activity of ciclacillin (ACPC) against clinically isolated strains (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1977 May; 30(5):315-20. PubMed ID: 17021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resurgence of penicillin-susceptible Staphylococcus aureus at a hospital in New York State, USA.
    Crane JK
    J Antimicrob Chemother; 2014 Jan; 69(1):280-1. PubMed ID: 23925938
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synergism of dicloxacillin and broad-spectrum penicillins].
    Savoia D; Fontana G; Cavallo G
    G Batteriol Virol Immunol; 1975; 68(7-12):270-8. PubMed ID: 1234593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
    Nissen JL; Skov R; Knudsen JD; Ostergaard C; Schønheyder HC; Frimodt-Møller N; Benfield T
    J Antimicrob Chemother; 2013 Aug; 68(8):1894-900. PubMed ID: 23599360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative experimental study of cyclacillin and ampicillin].
    Rudzit EA; Iakovlev VP; Zinchenko TA; Kulikova DA; Lisitsa LI
    Antibiotiki; 1979 May; 24(5):331-6. PubMed ID: 375825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the chemotherapeutic effectiveness of ciclacillin and ampicillin and the time of their administration in experimental infections.
    Arend P; Sous H; Poszich G; Mŭckter H
    Arzneimittelforschung; 1975 Sep; 25(9):1382-5. PubMed ID: 1103895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclacillin: microbiological and pharmacological properties and use in chemotherapy of infection - a critical appraisal.
    Warren GH
    Chemotherapy; 1976; 22(3-4):154-82. PubMed ID: 773605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dicloxacillin: its chemotherapeutic action and experimental kinetic characteristics].
    Lobuseva AN; Vasil'ev VK; Berezina EK; Speranskaia ON; Fomina IP
    Antibiotiki; 1975 Jun; 20(7):640-6. PubMed ID: 1225214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity of Staphylococcus aureus strains to dicloxacillin Polfa and serum concentrations of dicloxacillin sodium following oral administration].
    Szczygiel B; Switka S; Wencel J; Pertkiewicz M; Ruciński J; Schaeffer A; Zdziarska H
    Pol Tyg Lek; 1975 Dec; 30(52):2189-91. PubMed ID: 1042979
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new penicillin, dicloxacillin].
    Yoshioka H; Mori H; Itagaki M; Shibaki H; Nanbu H
    J Antibiot B; 1967 Feb; 20(1):34-6. PubMed ID: 5298992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.